Freiburg (dpa) - The legal dispute over possible health risks from taking the contraceptive pill "Yasminelle" now occupies the next instance.

The Karlsruhe Higher Regional Court held an appeal on Tuesday in Freiburg about a woman's claim for damages against the pharmaceutical distributor Bayer Vital GmbH (Az. 14 U 19/19).

At the hearing, an expert was asked, among other things, whether the damage to the woman's health could also be attributed to factors other than the “Yasminelle” pill.

A decision by the court should not be made until a later day.

The plaintiff suffered a bilateral pulmonary embolism and a circulatory collapse with cardiac arrest in July 2009 and narrowly escaped death.

She attributes this to the ingestion of the drug with its active ingredient drospirenone.

Bayer Vital GmbH considers the woman's claims to be unfounded.

In 2018, the now 36-year-old failed with her claim for damages before the Waldshut-Tiengen district court.

The court found that her health problems were not beyond doubt due to the use of "Yasminelle".

© dpa-infocom, dpa: 210504-99-461131 / 2


Judgment of the Waldshut-Tiengen Regional Court